Correlation Between Leukocyte Differential Counts with The Severity and Outcome of Coronavirus Disease 2019 (COVID-19) Patients In Jember
DOI:
https://doi.org/10.36497/jri.v41i3.186Keywords:
COVID-19, leukocyte differential counts, severity, outcomeAbstract
Background: Coronavirus Disease 2019 (COVID-19) is an acute respiratory disease caused by new strain of RNA viruses named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Hematological changes, especially leukocyte differential counts, presumed to be a predictor of the severity and outcome of COVID-19 patients. This study aimed to analyze the correlation between leukocyte differential counts with the severity and outcome of COVID-19 patients. Methods: This study was conducted using a cross-sectional analytic observational method, through secondary data analysis of COVID-19 patients who were tested positive by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) and hospitalized between April–November 2020 at Citra Husada Jember, Kaliwates Jember, and Jember Klinik Hospital. Results: From 267 patients, there were 139 female patients (52.1%) and 128 male patients (47.9%). There was a positive correlation on leukocytes, neutrophil, and neutrophil-lymphocyte ratio (NLR) with the severity and outcome of the patients, and negative correlation on eosinophils, lymphocytes, and monocytes (P 0.05) Conclusion: Leukocyte differential counts examination could be a predictor of the severity and outcome of COVID-19 patients, especially neutrophils, lymphocytes, and NLR.Downloads
References
Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol [Internet]. 2020;5(4):536–44. Available from: https://doi.org/10.1038/s41564-020-0695-z
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020;49(3):717–26.
World Health Organization. Coronavirus disease (COVID-19) [Internet]. 2020 [cited 2020 Jun 23]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Gugus Tugas Percepatan Penanganan COVID-19. Peta Sebaran COVID-19 di Indonesia [Internet]. [cited 2020 Sep 25]. Available from: https://covid19.go.id/peta-sebaran
Pemkab Jember. Data Update Gugus Tugas COVID-19 Kabupaten Jember [Internet]. 2020 [cited 2020 Jun 23]. Available from: https://www.jemberkab.go.id/
Kementrian Kesehatan Republik Indonesia (Kemenkes RI). Pedoman Pencegahan dan Pengendalian Coronavirus Disease (Covid-19) Revisi Ke-5. Jakarta; 2020.
Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020;508:254–66.
Violetis OA, Chasouraki AM, Giannou AM, Baraboutis IG. COVID-19 Infection and Haematological Involvement: a Review of Epidemiology, Pathophysiology and Prognosis of Full Blood Count Findings. SN Compr Clin Med. 2020;1–5.
Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. J Infect. 2020;80(6):607–13.
Zhao K, Li R, Wu X, Zhao Y, Wang T, Zheng Z, et al. Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis. Eur J Clin Microbiol Infect Dis. 2020;39(12):2279–87.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020;395(10223):507–13. Available from: https://doi.org/10.1016/S0140-6736(20)30211-7
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA [Internet]. 2020;323(11):1061–9. Available from: https://doi.org/10.1001/jama.2020.1585
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020;382(18):1708–20. Available from: https://doi.org/10.1056/NEJMoa2002032
Cron RQ, Behrens EM. Cytokine Storm Syndrome. 1st ed. Cytokine Storm Syndrome. Springer, Cham; 2019. 617 p.
Wang C, Deng R, Gou L, Fu Z, Zhang X, Shao F, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med. 2020;8(9):593.
Magdalena, Sugiri YJ, Tantular R, Listyoko A. Karakteristik Klinis Pasien COVID-19 di Rumah Sakit Dr. Saiful Anwar, Malang. J Respirologi Indones. 2021;41(1):7–10.
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–47.
Simadibrata DM, Calvin J, Wijaya AD, Ibrahim NAA. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis. Am J Emerg Med. 2021;42:60–9.
Jesenak M, Brndiarova M, Urbancikova I, Rennerova Z, Vojtkova J, Bobcakova A, et al. Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis. Front Cell Infect Microbiol. 2020;10:364.
Xie G, Ding F, Han L, Yin D, Lu H, Zhang M. The role of peripheral blood eosinophil counts in COVID-19 patients. Allergy. 2021;76(2):471–82.
Anurag A, Jha PK, Kumar A. Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients. Diabetes Metab Syndr. 2020;14(6):2099–102.
Martens RJH, van Adrichem AJ, Mattheij NJA, Brouwer CG, van Twist DJL, Broerse JJCR, et al. Hemocytometric characteristics of COVID-19 patients with and without cytokine Storm syndrome on the Sysmex XN-10 hematology analyzer. Clin Chem Lab Med. 2020;1–11.
Pence BD. Severe COVID-19 and aging: are monocytes the key? GeroScience [Internet]. 2020;42(4):1051–61. Available from: https://www.unboundmedicine.com/medline/citation/32556942/Severe_COVID_19_and_aging:_are_monocytes_the_key
Qin S, Jiang Y, Wei X, Liu X, Guan J, Chen Y, et al. Dynamic changes in monocytes subsets in COVID-19 patients. Hum Immunol. 2021;82(3):170–6.
Mousavi SA, Rad S, Rostami T, Rostami M, Mousavi SA, Mirhoseini SA, et al. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology. 2020;25(1):383–8.
Nair AP, Soliman A, Al Masalamani MA, De Sanctis V, Nashwan AJ, Sasi S, et al. Clinical Outcome of Eosinophilia in Patients with COVID-19: A Controlled Study. Acta Biomed. 2020;91(4):e2020165.
Asghar MS, Khan NA, Haider Kazmi SJ, Ahmed A, Hassan M, Jawed R, et al. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Community Hosp Intern Med Perspect. 2020;10(6):514–20.
Rodriguez L, Pekkarinen PT, Lakshmikanth T, Tan Z, Consiglio CR, Pou C, et al. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19. Cell reports Med. 2020;1(5):100078.
Yuan X, Huang W, Ye B, Chen C, Huang R, Wu F, et al. Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol. 2020;112(4):553–9.
Robb C, Regan K, Dorward D, Rossi A. Key mechanisms governing resolution of lung inflammation. Semin Immunopathol. 2016;38(4):425–48.
Deng Z, Zhang M, Zhu T, Zhili N, Liu Z, Xiang R, et al. Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19. Int J Infect Dis. 2020;98:353–8.
Downloads
Additional Files
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
